3D Global Biotech Inc. (6808)
Market Closed
16 Oct, 05:30 AM
TWSE TWSE Primary NT$
35. 00
+0.45
+1.3025%
NT$
- Market Cap
- P/E Ratio
0.02% Div Yield
39,543 Volume
0 Eps
NT$ 34.55
Previous Close Want to track 6808 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3D Global Biotech Inc. (6808) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.67B
Trailing P/E (ttm) 181.84
Forward P/E -
PEG ratio -2.02
Price/Sales (ttm) 16.71
Price/Book (mrq) 3.63
Enterprise Value/Revenue 16.8
Enterprise Value/EBITDA 141.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 104.94K
Average volume (90 days) 210.62K
Price summary
52-Week low 22.45
52-Week high 63
Beta -
50-Day moving average 32.28
200-Day moving average 32.96
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.13
Trailing annual dividend yield 0.0038%
5-Year annual dividend yield -
Payout ratio 2.91
Dividend Date 10 Aug 2026
Ex-Dividend Date 16 Jul 2026
Last split factor 1,013:1,000
Last split Date 31 Jul 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.09%
Operating margin -0.04%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.46
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 11.61%
Book value per share (mrq) 9.52
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
